C & A Naturistics sold unapproved new drugs online, including AK Forte with hidden acetaminophen and diclofenac.
What happened
FDA reviewed the company’s website from May 2024 to February 2025 and found products marketed with claims to treat cancer, arthritis, kidney stones, infections, and other diseases. FDA also obtained and lab-tested a sample of AK Forte and found undeclared acetaminophen and diclofenac; the website also offered eye products for conjunctivitis and eyelid infections.
What FDA found
The products are unapproved new drugs because they are intended to treat diseases but have no FDA-approved drug applications.
sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d)AK Forte is misbranded because its labeling does not disclose that it contains acetaminophen and diclofenac.
section 502(a) of the FD&C Act, 21 U.S.C. 352(a)TE DE MORONEL, Jengibre en Polvo, Té Uva Ursi, and RenaLimp are misbranded because they lack adequate directions for use by a layperson.
section 502(f)(1) of the FD&C Act, 21 U.S.C. 352(f)(1); 21 CFR 201.5AK Forte is excluded from being a dietary supplement because it contains diclofenac, which was approved as a drug before being marketed as a supplement or food.
section 201(ff)(3)(B)(i) of the FD&C Act, 21 U.S.C. 321(ff)(3)(B)(i)The website made drug claims for the products, such as treating cancer, arthritis, kidney stones, and conjunctivitis.
section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the steps taken to correct the violations, with explanations and supporting documents, sent to FDAAdvisory@fda.hhs.gov with “CMS 693439” in the subject line.
Who should pay attention
- retailers and online sellers of herbal or imported products
- distributors and brands offering products with disease-treatment claims
- consumers using imported herbal supplements or eye drops
This is a summary. Read the original letter on fda.gov.